Rafael Henrique | Light Rocket | Getty Images Enlightenment on Thursday urged shareholders to reject Carl Icahn’s three board nominees at this year’s annual meeting because they would “endanger” the progress of the biotech’s core business. “Carl Icahn’s participation in Illumina puts the company’s long-term success at risk, and its nominee directors do not bring …
Continue reading “Illumina Urges Shareholders to Reject Carl Icahn’s Board Nominees”